Aridis Pharmaceuticals (NASDAQ: [[ticker:ARDS]]) has appointed Michael Nazak to the role of chief financial officer. He succeeds Fred Kurland, who has retired but will continue working with the San Jose, CA-based company as a consultant.
Nazak joined Aridis in late 2018 as the vice president of finance. Previously, he served as senior vice president of finance at Coherus Biosciences and the senior director of finance and accounting at InteKrin Therapeutics. He also has held roles at Reliant Technologies and Connetics Corporation.